WHO's New TB Tests Cut Costs in Half, Save Lives Faster

Imagine a test that fits in a backpack, runs on batteries, and could save your life in under an hour. That's exactly what the World Health Organization just recommended for tuberculosis detection, and it's arriving at the perfect time for the 3,300 people who die from TB every day.

The new diagnostic tools cost less than half the price of current molecular tests and work right where patients seek care, eliminating the need to transport samples to distant laboratories. They deliver accurate results in less than 60 minutes, allowing people to start treatment the same day instead of waiting days or weeks.

TB remains one of the world's deadliest infectious killers, but global efforts have already saved 83 million lives since 2000. These new tools could accelerate that progress dramatically by reaching people in remote areas who previously had no access to fast, reliable testing.

The guidelines also introduce tongue swabs as an alternative for adults and teens who can't produce sputum samples. This simple change means thousands of high-risk patients who were previously unable to get tested can now receive a diagnosis for the first time.

Beyond tuberculosis, these portable devices can test for HIV, mpox, and HPV, transforming them into versatile diagnostic hubs. Health systems can now offer one-stop-shop services for multiple diseases using the same equipment.

The Ripple Effect

Every dollar invested in TB programs generates up to $43 in health and economic returns, according to WHO estimates. When people get diagnosed and treated faster, they return to work sooner, stop spreading the disease to family members, and require less intensive medical care.

The impact extends beyond individual patients. Faster diagnosis means faster treatment, which dramatically reduces transmission rates in communities where TB spreads most easily. One person diagnosed early could prevent dozens of new infections.

These affordable, portable tests are especially transformative for countries with limited healthcare budgets. The sputum pooling strategy recommended in the guidelines allows labs to test multiple samples together, cutting costs and machine time while delivering faster results to patients and TB programs.

The innovations arrive as global health funding faces serious cuts that threaten to reverse decades of progress. Making diagnostics more accessible and affordable helps protect those hard-won gains even during resource constraints.

WHO Director-General Dr. Tedros Adhanom Ghebreyesus called the tools "truly transformative," urging all countries to scale up access so every person with TB can be reached and treated promptly. The technology exists, the science is proven, and the path forward is clear.

With more than 29,000 people still falling ill with this preventable and curable disease each day, faster diagnosis isn't just about individual lives—it's about breaking the chain of transmission that has made TB a leading killer for far too long.